Yesterday morning Apple was granted patent 10,568,533 for techniques that provide electronic devices with faster, more efficient methods and interfaces for managing health monitoring on an Apple Watch or iPhone. More specifically, Apple's patent covers their use of an ECG App UI. Apple is now shifting gears to tackle a new health study related to stroke prevention using an iPhone and/or Apple Watch.
It was announced yesterday afternoon that Apple was partnering with Johnson & Johnson to reduce the risk of strokes in senior citizens over the age of 65 (with a traditional Medicare plan).
Such seniors would be eligible to participate in clinical research through the Heartline Study app on iPhones. They'll also have access to heart health features on Apple Watch models. The patients must also agree to provide access to their Medicare claims data.
Dr. Paul Burton, vice president of medical affairs for J&J's Janssen Pharmaceutical Companies unit told CNN that "Heartline could go down as a landmark clinical trial. We are bringing amazing digital wearable tech and engagement apps for healthcare to patients and doctors."
The study is designed to detect atrial fibrillation or AFib, an irregular heart rhythm that is a leading cause of stroke. Burton added that "AFib can potentially lead to more strokes for people over the age of 65. Cases are more common. And people fear having a stroke as much as dying."
In a statement issued Tuesday by Apple's head of health strategic initiatives Myoung Cha, he stated that "The Heartline Study will help further understanding of how our technology could both contribute to science and help improve health outcomes, including reducing the risk of stroke." For more on this, read the full CNN report.